Van Den Berg Management I’s Harvard Bioscience HBIO Stock Holding History

Van Den Berg Management I’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-25,229	Closed	-$1.43M	–	99
2014 Q4	$1.43M	Sell	25,229 -1,063	-4%	-$50.7K	0.13%	65
2014 Q3	$1.07M	Buy	26,292 +730	+3%	+$33.6K	0.08%	71
2014 Q2	$1.16M	Buy	25,562 +3,173	+14%	+$133K	0.08%	70
2014 Q1	$1.06M	Buy	22,389 +109	+0.5%	+$4.96K	0.07%	74
2013 Q4	$1.05M	Buy	22,280 +6,681	+43%	+$292K	0.08%	67
2013 Q3	$622K	Buy	+15,599	New	+$613K	0.05%	67

Other funds holding HBIO

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Van Den Berg Management I's HBIO Position: Q1 2015 in Review

Van Den Berg Management I sold out of Harvard Bioscience (HBIO) in Q1 2015, closing a stake of 25,229 shares — an estimated $1.43M sold.

Van Den Berg Management I first reported a position in HBIO in Q3 2013 and held it in 6 quarters. The position peaked at $1.43M in Q4 2014. 79 funds tracked by Wall St. Rank hold HBIO as of Q1 2015.

Van Den Berg Management I reported no remaining Harvard Bioscience position as of Q1 2015 after selling out during the quarter.
Van Den Berg Management I sold 25,229 Harvard Bioscience shares in Q1 2015, an estimated $1.43M.
Van Den Berg Management I first reported a position in Harvard Bioscience in Q3 2013 and held it in 6 quarters.
Van Den Berg Management I's Harvard Bioscience position peaked at $1.43M in Q4 2014.
79 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2015.

Based on Van Den Berg Management I's 13F filing for Q1 2015, filed 15 May 2015.